These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11020757)

  • 1. Dose-response and onset/offset characteristics of rapacuronium.
    Kopman AF; Klewicka MM; Ghori K; Flores F; Neuman GG
    Anesthesiology; 2000 Oct; 93(4):1017-21. PubMed ID: 11020757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide.
    Wright PM; Brown R; Lau M; Fisher DM
    Anesthesiology; 1999 Jan; 90(1):16-23. PubMed ID: 9915308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potency (ED50) and cardiovascular effects of rapacuronium (Org 9487) during narcotic-nitrous oxide-propofol anesthesia in neonates, infants, and children.
    Kaplan RF; Fletcher JE; Hannallah RS; Bui DT; Slaven JS; Darrow EJ; Tsai KT
    Anesth Analg; 1999 Nov; 89(5):1172-6. PubMed ID: 10553829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrhosis.
    Duvaldestin P; Slavov V; Rebufat Y
    Anesthesiology; 1999 Nov; 91(5):1305-10. PubMed ID: 10551581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion.
    Fisher DM; Dempsey GA; Atherton DP; Brown R; Abengochea A; Hunter JM
    Anesthesiology; 2000 Dec; 93(6):1384-91. PubMed ID: 11149430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous recovery profile of rapacuronium during desflurane, sevoflurane, or propofol anesthesia for outpatient laparoscopy.
    Zhou TJ; Coloma M; White PF; Tang J; Webb T; Forestner JE; Greilich NB; Duffy LL
    Anesth Analg; 2000 Sep; 91(3):596-600. PubMed ID: 10960383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset/offset characteristics and intubating conditions of rapacuronium: a comparison with rocuronium.
    Zhou TJ; White PF; Chiu JW; Joshi GP; Dullye KK; Duffy LL; Tongier WK
    Br J Anaesth; 2000 Aug; 85(2):246-50. PubMed ID: 10992833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of maintenance bolus on the recovery profile of a short-acting nondepolarizing muscle relaxant.
    Chen X; Tang J; White PF; Wender RH; Sloninsky A; Naruse R; Kariger R; Webb T; Norel E
    J Clin Anesth; 2002 Nov; 14(7):500-4. PubMed ID: 12477584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide.
    Szenohradszky J; Caldwell JE; Wright PM; Brown R; Lau M; Luks AM; Fisher DM
    Anesthesiology; 1999 Jan; 90(1):24-35. PubMed ID: 9915309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholine.
    Miguel R; Witkowski T; Nagashima H; Fragen R; Bartkowski R; Foldes FF; Shanks C
    Anesthesiology; 1999 Dec; 91(6):1648-54. PubMed ID: 10598606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The time-course of action of rapacuronium and mivacurium after early reversal following equally lasting relaxation].
    Geldner G; Lang C; Hoffmann W; Hossfeld A; Weinberger J; Eble M; Blobner M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):594-9. PubMed ID: 12975739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
    Wight WJ; Wright PM
    Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of action of vecuronium after an intubating dose of rapacuronium, vecuronium, or succinylcholine.
    Gan TJ; Madan R; Alexander R; Jhaveri R; El-Moalem H; Weatherwax K; Glass PS
    Anesth Analg; 2001 May; 92(5):1199-202. PubMed ID: 11323346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular effects of rapacuronium in pediatric patients during nitrous oxide-halothane anesthesia: comparison with mivacurium.
    Brandom BW; Margolis JO; Bikhazi GB; Ross AK; Ginsberg B; Dear G; Kenaan CA; Eck JB; Woelfel SK; Lloyd ME
    Can J Anaesth; 2000 Feb; 47(2):143-9. PubMed ID: 10674508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early reversal of rapacuronium with neostigmine.
    Purdy R; Bevan DR; Donati F; Lichtor JL
    Anesthesiology; 1999 Jul; 91(1):51-7. PubMed ID: 10422928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the intubation conditions provided by rapacuronium (ORG 9487) or succinylcholine in humans during anesthesia with fentanyl and propofol.
    Fleming NW; Chung F; Glass PS; Kitts JB; Kirkegaard-Nielsen H; Gronert GA; Chan V; Gan TJ; Cicutti N; Caldwell JE
    Anesthesiology; 1999 Nov; 91(5):1311-7. PubMed ID: 10551582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular rapacuronium in infants and children: dose-ranging and tracheal intubating conditions.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 1999 Nov; 91(5):1285-92. PubMed ID: 10551578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of rapacuronium block during propofol versus sevoflurane anesthesia.
    Zhou TJ; Tang J; White PF; Joshi GP; Wender R; Murphy MT; Chiu JW; Webb T
    Anesth Analg; 2000 Mar; 90(3):689-93. PubMed ID: 10702458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.